Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski evaluated the potential risk of retinal detachment (RD) associated with these medications.
Although no cases of RD were linked to quinolones in clinical trials, some reports of RD were noted in the US FDA Adverse Event Reporting System in conjunction with systemic use of quinolone antibiotics. Analysis of electronic health records from over 500 US healthcare institutions revealed elevated but non-significant risks in African Americans (ciprofloxacin and levofloxacin), those aged 56–70 years old (moxifloxacin), and women (ciprofloxacin).
The authors noted that these suggestions of increased risk observed in some population subgroups warrant further investigation.
Posted in RSI News
More RSI News
RSI and Engineers Canada develop on-line training courses
Engineers Canada has retained Risk Sciences International’s (RSI) Climate Group to develop training course modules and to deliver on-line training to Professional Engineers seeking to…
Read News ItemRoger Rempel joins RSI as Director of Climate Group
RSI is pleased to announce that Roger Rempel has joined us as the Director of the RSI Climate Group. Roger is a senior environmental engineer…
Read News ItemNorman Shippee joins RSI
RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the…
Read News ItemEmma Hartnett receives Chauncey Starr Distinguished Young Risk Analyst Award
The Society for Risk Analysis (SRA) Council has awarded Dr. Hartnett the 2016 Chauncey Starr Distinguished Young Risk Analyst Award. The Chauncey Starr Distinguished Young…
Read News Item